Digna R. Velez Edwards
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (9)
Year:
2026
Keloids are raised scars that grow beyond original wound boundaries, resulting in pain and disfigurement. Reasons for keloid development are not well-understood, and current treatment options are limited. Keloids are more likely to occur in darker-skinned individuals of African and Asian descent than in Europeans. We performed a genome-wide association study (GWAS) examining keloid risk across and within continental ancestry groups, incorporating 7837 cases and 1,593,009 controls. We detected 26 loci in the multi-ancestry analysis, 12 of which replicated in an independent dataset. Heritability estimates were 6%, 21%, and 34% for the European, East Asian, and African ancestry analyses, respectively. Genetically predicted gene expression and colocalization analyses identified 27 gene-tissue pairs, nine in skin and fibroblasts. Pathway analyses implicated integrin signaling and upstream regulators involved in cancer, fibrosis, and sex hormone signaling. This investigation nearly quintuples the number of keloid-associated risk loci, illuminating biological processes in keloid pathology.
Year:
2025
Table S1. Clinical and demographic characteristics of the colorectal cancer (CRC) patient study population by race/ethnicity and age at sequencing: AACR Project GENIE.Table S2. Baseline mutation probability, comparison and heterogeneity of non-silent somatic gene mutations among patients with early-onset and late-onset nonhypermutated colorectal cancer. Genes ranked by false discovery rate (FDR).Table S3. Racial/ethnic patterns in baseline mutation probability, comparison and heterogeneity of all non-silent somatic gene mutations among patients with early-onset and late-onset non-hypermutated colorectal cancer.Table S4. Baseline mutation probability, comparison and heterogeneity of non-silent somatic gene mutations among patients with earlyonset and late-onset non-hypermutated colorectal cancer by sex.Table S5. Read depth for clinical-grade targeting sequencing data from tumor tissues and case counts by early-onset and late-onset groups and sequencing center. Figure S1. Mutation rates among 6,903 tumor samples from colorectal cancer patients across racial/ethnic groups.Figure S2. Adjusted mutation rates in 653 hypermutated colorectal tumors: AACR GENIE.Figure S3. Tumor mutational burden (TMB) across sequencing assay/platform for early-onset and late-onset non-hypermutated colorectal cancer cases: AACR Project GENIE.Figure S4. Frequency of non-silent somatic mutations in commonly assayed and mutated genes between early-onset and late-onset non-hypermutated CRC cases (mutation frequency >10%).
Year:
2025
We report the findings of a genome-wide association study (GWAS) meta-analysis of endometriosis across 14 biobanks worldwide, including 32% non-European patient participants, as part of the Global Biobank Meta-Analysis Initiative (GBMI). Out of 58 total loci (29 previously unreported), the largest meta-analysis accounted for 46 (20 previously unreported). We detected the first genome-wide significant loci (2p13.3 and 20q13.2) uniquely driven by the African-ancestry meta-analysis. Our imaging- and surgery-confirmed phenotypes yielded six additional previously unreported loci. Leveraging our large and diverse study population, we observed SNP heritability estimates of 9-13% for all ancestry groups, and 13 loci had at least one variant in the credible set after fine-mapping. Investigating the complex array of endometriosis comorbidities and risk factors revealed 135 genetically correlated phenotypes and 95 with evidence of vertical pleiotropy, including triglycerides and anxiety disorders. We prioritized 35 disease-relevant cellular contexts from the endometrial cell atlas and found 322 examples of differentially expressed genes in cells from donors with endometriosis. Further high-throughput multi-omic analyses implicated a total of 282 genes in endometriosis pathogenesis. Our diverse, comprehensive GWASs, with downstream analyses spanning molecular to phenotypic scales, provide detailed evidence for aspects of endometriosis including the role of immune cell types, Wnt signaling, and cellular proliferation. These interconnected pathways and risk factors underscore the complex, multi-faceted etiology of endometriosis, suggesting multiple targets for precise and effective therapeutic interventions.
Year:
2025
Many complex traits in humans exhibit sex differences. Recent advances in understanding context-specific genetic effects underscore the imperative for sex-aware genetic analyses to assess the role of sex in the genetic basis of human phenotypes. Despite increasing recognition of the importance of sex as a biological variable, current computational tools for genome-wide association studies (GWAS) lack functionality for performing nuanced sex-aware quality control and analysis. In response, we present GXwasR, a comprehensive R package that implements statistical genetic models for performing both GWAS and X-Chromosome-Wide Association Studies (XWAS). Designed for both sex-combined and sex-stratified analyses, GXwasR can account for unique features of chromosome X, including X-chromosome inactivation. Beyond enabling association analysis and meta-analysis, the tool has functions to a) test for sex differences in SNP-level genetic effects and heritability, b) assess genetic correlation, c) compute sex-aware polygenic risk scores (PRS), and d) support enhanced quality control protocols expressly designed for these purposes. GXwasR thus serves as a computational resource to enable investigations into the role of sex in the genetic basis of complex human phenotypes.
Year:
2025
Keloids are raised scars that grow beyond original wound boundaries, resulting in pain and disfigurement. Reasons for keloid development are not well-understood, and current treatment options are limited. Keloids are more likely to occur in darker-skinned individuals of African and Asian descent than in Europeans. We performed a genome-wide association study (GWAS) examining keloid risk across and within continental ancestry groups, incorporating 7,837 cases and 1,593,009 controls. We detected 21 novel independent loci in the multi-ancestry analysis, including several previously associated with fibroproliferative disorders. Heritability estimates were 6%, 21%, and 34% for the European, East Asian, and African ancestry analyses, respectively. Genetically predicted gene expression and colocalization analyses identified 27 gene-tissue pairs, including nine in skin and fibroblasts. Pathway analysis implicated integrin signaling and upstream regulators involved in cancer, fibrosis, and sex hormone signaling. This investigation nearly quintuples the number of keloid-associated risk loci, illuminating biological processes in keloid pathology.
Year:
2025
Molecular features underlying colorectal cancer disparities remain uncharacterized. Here, we investigated somatic mutation patterns by race/ethnicity and sex among 5,856 non-Hispanic white (NHW), 535 non-Hispanic Black (NHB), and 512 Asian/Pacific Islander (API) patients with colorectal cancer (2,016 early-onset colorectal cancer patients: sequencing age LRP1B, FLT4, FBXW7, RNF43, ATRX, APC , and PIK3CA mutation frequencies in early-onset nonhypermutated colorectal cancers between racial/ethnic groups. Heterogeneities by race/ethnicity were observed for the effect of APC, FLT4 , and FAT1 between early-onset and late-onset nonhypermutated colorectal cancer. By sex, heterogeneity was observed for the effect of EP300, BRAF, WRN, KRAS, AXIN2 , and SMAD2 . Males and females with nonhypermutated colorectal cancer had different trends in EP300 mutations by age group. These findings define genomic patterns of early-onset nonhypermutated colorectal cancer by race/ethnicity and sex, which yields novel biological clues into early-onset colorectal cancer disparities. Significance: NHBs, but not APIs, with early-onset nonhypermutated colorectal cancer had higher adjusted tumor mutation rates versus NHWs. Differences for FLT4 , FBXW7 , RNF43 , LRP1B , APC , PIK3CA , and ATRX mutation rates between racial/ethnic groups and EP300 , KRAS , AXIN2 , WRN , BRAF , and LRP1B mutation rates by sex were observed in tumors of young patients. See related commentary by Shen et al., p. 530 . This article is highlighted in the In This Issue feature, p. 517
Year:
2025
We report the findings of a genome-wide association study (GWAS) meta-analysis of endometriosis across 14 biobanks worldwide, including 32% non-European patient participants, as part of the Global Biobank Meta-Analysis Initiative (GBMI). Out of 58 total loci (29 previously unreported), the largest meta-analysis accounted for 46 (20 previously unreported). We detected the first genome-wide significant loci ( 2p13.3 and 20q13.2 ) uniquely driven by the African-ancestry meta-analysis. Our imaging- and surgery-confirmed phenotypes yielded six additional previously unreported loci. Leveraging our large and diverse study population, we observed SNP heritability estimates of 9-13% for all ancestry groups, and 13 loci had at least one variant in the credible set after fine-mapping. Investigating the complex array of endometriosis comorbidities and risk factors revealed 135 genetically correlated phenotypes and 95 with evidence of vertical pleiotropy, including triglycerides and anxiety disorders. We prioritized 35 disease-relevant cellular contexts from the endometrial cell atlas and found 322 examples of differentially expressed genes in cells from donors with endometriosis. Further high-throughput multi-omic analyses implicated a total of 282 genes in endometriosis pathogenesis. Our diverse, comprehensive GWASs, with downstream analyses spanning molecular to phenotypic scales, provide detailed evidence for aspects of endometriosis including the role of immune cell types, Wnt signaling, and cellular proliferation. These interconnected pathways and risk factors underscore the complex, multi-faceted etiology of endometriosis, suggesting multiple targets for precise and effective therapeutic interventions.
Year:
2024
Diseases such as uterine leiomyomata (fibroids and benign tumors of the uterus) and keloids (raised scars) may share common etiology. Fibroids and keloids can co-occur in individuals, and both are highly heritable, suggesting they may share common genetic risk factors. Fibroproliferative diseases are common and characterized by scarring and overgrowth of connective tissue, impacting multiple organ systems. These conditions both have racial disparities in prevalence, with the highest prevalence observed among individuals of African ancestry. Several fibroproliferative diseases are more severe and common in populations of sub-Saharan Africa. This mini-review aims to provide a broad overview of the current knowledge of the evolutionary origins and causes of fibroproliferative diseases. We also discuss current hypotheses proposing that the increased prevalence of these diseases in African-derived populations is due to the selection for profibrotic alleles that are protective against helminth infections and provide examples from knowledge of uterine fibroid and keloid research.
Year:
2023
Collaborators (22)
José Perea
-
Yuan Luo
Chief AI Officer and Associate Professor
Northwestern University
Mary K WASHINGTON
Vanderbilt University Medical Center
Yuji Yamamoto
Osaka University Graduate School of Medicine
Alexandra Sundermann
Assistant Professor
Vanderbilt University Medical Center
Wei Zheng
-
Jacklyn N. Hellwege
Vanderbilt University Medical Center
Alan Sanders
Clinical Associate Professor of Psychiatry
NorthShore University HealthSystem
Atlas Khan
Assistant professor
Columbia University
Barbara Stranger
Associate Professor
Northwestern University Feinberg School of Medicine
Lea Davis
Professor
Vanderbilt University
Megan M Shuey
Vanderbilt University Medical Center
Jonathan Shortt
Assistant Research Professor
University of Colorado Anschutz Medical Campus
Xingyi Guo
Associate Professor
Vanderbilt University Medical Center
Andreana N. Holowatyj
Vanderbilt University Medical Center
Jeewoo Kim
Vanderbilt University
Todd Edwards
Assistant Professor
Vanderbilt University
Michelle Liu
Vanderbilt University Medical Center
Cathy Eng
Professor; Associate Director for Strategic Relations and Research Partnerships
Vanderbilt University Medical Center
Yukinori Okada
University of Tokyo
Maria Niarchou
Senior Scientist
Vanderbilt University Medical Center
WeiQi Wei
Professor
Vanderbilt University Medical Center
Make your next move.
Prepare your application
Review drafts before you send them.